|
EP1712226A3
(en)
*
|
1996-04-05 |
2007-03-21 |
The General Hospital Corporation |
Treatment of a Hemoglobinopathy
|
|
US6315995B1
(en)
*
|
1996-09-27 |
2001-11-13 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating an ischemic disorder and improving stroke outcome
|
|
US8128963B2
(en)
|
1996-09-27 |
2012-03-06 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating ischemic disorders using carbon monoxide
|
|
WO1999049803A1
(en)
*
|
1998-04-01 |
1999-10-07 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
|
|
US7678390B2
(en)
|
1999-04-01 |
2010-03-16 |
Yale University |
Carbon monoxide as a biomarker and therapeutic agent
|
|
FR2816212A1
(fr)
*
|
2000-11-03 |
2002-05-10 |
Air Liquide Sante Int |
Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
|
|
US20030198639A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Frenette Paul S. |
Methods of treating sickle cell disease
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
BR0210599A
(pt)
|
2001-06-21 |
2004-07-20 |
Beth Israel Hospital |
Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
|
|
US6472390B1
(en)
*
|
2001-11-13 |
2002-10-29 |
Duke University |
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
|
|
EP2042181A1
(en)
|
2002-02-04 |
2009-04-01 |
ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. |
Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
|
|
BRPI0307673A2
(pt)
*
|
2002-02-13 |
2016-11-08 |
Beth Israel Hospital |
métodos de tratar doença vascular.
|
|
EA200401365A1
(ru)
*
|
2002-04-15 |
2005-04-28 |
Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн |
Способы лечения илеуса
|
|
CA2482260A1
(en)
|
2002-04-15 |
2003-10-30 |
Beth Israel Deaconess Medical Center Inc. |
Use of heme oxygenase-1 and products of heme degradation
|
|
CA2481786A1
(en)
*
|
2002-04-15 |
2003-10-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods of treating necrotizing enterocolitis
|
|
HRP20041071A2
(en)
|
2002-05-17 |
2005-06-30 |
Yale University University of Pittsburgh of the Commonwealth Syste |
Methods of treating hepatitis
|
|
DE10230165A1
(de)
|
2002-07-04 |
2004-01-15 |
Ino Therapeutics Gmbh |
Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
|
|
CN1719975A
(zh)
*
|
2002-11-07 |
2006-01-11 |
联邦高等教育系统匹兹堡大学 |
出血性休克的治疗
|
|
AU2004285468B2
(en)
|
2003-10-22 |
2011-02-24 |
Fred Hutchinson Cancer Research Center |
Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
|
|
EP1552840A1
(en)
*
|
2004-01-07 |
2005-07-13 |
Aga Ab |
Use of a xenon/carbon monoxide mixture for the protection of cells
|
|
DK2264043T3
(da)
|
2005-09-02 |
2018-01-29 |
Glycomimetics Inc |
Heterobifunktionelle pan-selektin-inhibitorer
|
|
WO2009126556A1
(en)
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
EP2356224A4
(en)
*
|
2008-11-10 |
2012-12-26 |
Sinai School Medicine |
METHOD OF INHIBITING WEB TREATMENT IN CONNECTION WITH INFLAMMATION THROUGH NEUTROPHILACTIVITY INHIBITION
|
|
CN101732348B
(zh)
*
|
2008-11-11 |
2015-01-14 |
威世药业（如皋）有限公司 |
牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
JP6134710B2
(ja)
|
2011-07-21 |
2017-05-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化ルテニウム放出分子およびその使用
|
|
US9109002B2
(en)
|
2011-12-22 |
2015-08-18 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
|
WO2013162078A1
(ja)
*
|
2012-04-27 |
2013-10-31 |
学校法人日本大学 |
上皮及び内皮損傷の治療剤
|
|
LT2928476T
(lt)
|
2012-12-07 |
2018-05-25 |
Glycomimetics, Inc. |
Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
|
|
PL3227310T3
(pl)
|
2014-12-03 |
2020-02-28 |
Glycomimetics, Inc. |
Heterodwufunkcyjne inhibitory selektyn E i receptorów chemokinowych CXCR4”
|
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
|
JP2019524791A
(ja)
|
2016-08-08 |
2019-09-05 |
グリコミメティクス， インコーポレイテッド |
Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ
|
|
CN109890421B
(zh)
|
2016-10-07 |
2023-10-20 |
糖模拟物有限公司 |
高效的多聚体e-选择蛋白拮抗剂
|
|
US11197877B2
(en)
|
2017-03-15 |
2021-12-14 |
Glycomimetics. Inc. |
Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
|
|
US11712446B2
(en)
|
2017-11-30 |
2023-08-01 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
EP3732186A1
(en)
|
2017-12-29 |
2020-11-04 |
GlycoMimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|
|
KR20200128025A
(ko)
|
2018-03-05 |
2020-11-11 |
글리코미메틱스, 인크. |
급성 골수성 백혈병 및 관련 병태의 치료 방법
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
US20230263832A1
(en)
*
|
2020-07-10 |
2023-08-24 |
Children's Medical Center Corporation |
Targeted drug delivery to sites of intravascular occlusion
|